Nanjing Pharmaceutical Group Company Limited

¥5.32As of Sun 8 Nov 2026, 12:00 UTC
SSE:600713Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (2.36%)
Div yield 3.38%
ROE 10.14%
Drug Manufacturers (General)
Beta (5Y) 0.20
PE TTM 12.39
TSR TTM 10.64%
Mkt cap ¥6.959B
ROIC 5.91%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥6.89
29.59%
(50.48%)
Hold 5|3|4|12|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.07
0.07
0.06
0.07
13.96%
0.88%
(8.27%)
0.63%
Revenue¥M
495.1
523.9
537.5
568.0
14.01%
15.59%
12.94%
21.45%
Peers (US$1.043B)
Cap (US$)
PE
1.306B
14.10x
934.1M
115.0x
1.197B
—
Capital
TTM
5Y
10Y
Leveragex
2.850
6.118
5.052
EBIT/Intx
0.408
0.099
0.096
Own earn%
(2.90)
(144.17)
(129.02)
Sh yield%
29.84
19.07
17.40
Owners
Insiders/Inst%
11.03
67.43
Short interest%
2.92
SBC / revenue%
4.17
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
11–17
$1 testx
0.0
Incr. ROIC%
7